Next Gen Factory Vendor Agnostic Equipment User Requirement Specifications

Harmonized, supplier-agnostic equipment URS will streamline procurement, cut engineering effort, and support regulatory compliance. A shared framework improves communication, reduces rework, and boosts supply-chain resilience across biopharma.

Industry Need

Biopharmaceutical manufacturers lack shared, supplier-agnostic equipment user requirement specifications (URS) for major process steps in therapeutic antibody production. Current equipment URS documents are typically supplier specific and inconsistent across the industry, leading to inefficiencies in capital procurement, increased engineering costs, and challenges with maintaining regulatory compliance.

Approach

This project will develop harmonized, supplier-agnostic equipment user requirement specifications (URS) to provide a common framework that aligns with industry best practices and regulatory expectations, enabling manufacturers to streamline equipment procurement and qualification.

Impacts

Ready-to-use equipment URS templates will significantly reduce time and effort for manufacturers in drafting, reviewing, and negotiating equipment specifications.

Manufacturers will gain flexibility to source equipment from multiple vendors mitigating risks from reliance on a single supplier.

Aligning with widely adopted URS templates will empower suppliers to design equipment that broadly meets the expectations of customers and strengthen their position in the industry.

Value Statement/Outcomes

By using supplier-agnostic equipment URS documents, both manufacturers and suppliers will have a shared framework for communication and streamlined processes for equipment procurement. Over time, suppliers will be better positioned to propose designs that meet expectations without the need for extensive rework. Manufacturers will see benefits in supply chain resilience with the ability to qualify multiple suppliers against benchmark requirements.